全文获取类型
收费全文 | 78598篇 |
免费 | 6993篇 |
国内免费 | 3583篇 |
专业分类
耳鼻咽喉 | 776篇 |
儿科学 | 834篇 |
妇产科学 | 1315篇 |
基础医学 | 11246篇 |
口腔科学 | 1804篇 |
临床医学 | 8023篇 |
内科学 | 13738篇 |
皮肤病学 | 1225篇 |
神经病学 | 5191篇 |
特种医学 | 2904篇 |
外国民族医学 | 24篇 |
外科学 | 10071篇 |
综合类 | 8692篇 |
现状与发展 | 13篇 |
一般理论 | 9篇 |
预防医学 | 4818篇 |
眼科学 | 2032篇 |
药学 | 7462篇 |
35篇 | |
中国医学 | 2443篇 |
肿瘤学 | 6519篇 |
出版年
2024年 | 120篇 |
2023年 | 696篇 |
2022年 | 1657篇 |
2021年 | 2201篇 |
2020年 | 1610篇 |
2019年 | 1712篇 |
2018年 | 2162篇 |
2017年 | 1814篇 |
2016年 | 1756篇 |
2015年 | 2210篇 |
2014年 | 2913篇 |
2013年 | 3009篇 |
2012年 | 4202篇 |
2011年 | 4255篇 |
2010年 | 2611篇 |
2009年 | 2291篇 |
2008年 | 3114篇 |
2007年 | 3233篇 |
2006年 | 3055篇 |
2005年 | 2682篇 |
2004年 | 2134篇 |
2003年 | 2153篇 |
2002年 | 2012篇 |
2001年 | 5193篇 |
2000年 | 5102篇 |
1999年 | 4470篇 |
1998年 | 1733篇 |
1997年 | 1367篇 |
1996年 | 849篇 |
1995年 | 753篇 |
1994年 | 670篇 |
1993年 | 560篇 |
1992年 | 2063篇 |
1991年 | 1807篇 |
1990年 | 1598篇 |
1989年 | 1547篇 |
1988年 | 1366篇 |
1987年 | 1243篇 |
1986年 | 1089篇 |
1985年 | 919篇 |
1984年 | 606篇 |
1983年 | 473篇 |
1982年 | 253篇 |
1981年 | 189篇 |
1980年 | 143篇 |
1979年 | 284篇 |
1978年 | 80篇 |
1974年 | 76篇 |
1973年 | 95篇 |
1972年 | 73篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer’s Disease
In order to solve the problem of long-term (>9 months) efficacy in the treatment of Alzheimer''s disease (AD) by conventional therapy (CT), a staged and multiply-targeted sequential therapy based on the evolvement of patterns (STEP) was developed. Its main innovations include: (1) the time order of evolution of patterns defined by Chinese medicine (CM) in AD was found, that is, "the orderly pattern evolution starting from Shen (Kidney) deficiency, progressing to phlegm, stasis and fire, and worsening to severe toxin as well as functional collapse"; (2) the cascade hypothesis of Shen deficiency in AD and its sequential therapy based on Shen-reinforcing was proposed, that is, "reinforcing Shen in the early stage and throughout the whole process, resolving phlegm, activating blood and purging fire in the middle stage, detoxifying and replenishing vitality to stop the collapse in the advanced stage", and through meta-analysis, clinical drug use was optimized, thus the leap from "inferential selection" to "evidence-based selection" was realized; (3) the STEP regimen combined with CT maintained cognitive and behavioral stability in AD patients for at least 12 months, with cognitive enhancement and behavioral synergy after 9 months, and cognitive benefit was superior to CT at 9, 12, 15, 18, 21, and 24 months, respectively. The 2-year cognitive improvement rate was increased by 25.64% (P=0.020) and the cognitive deterioration rate was decreased by 48.71% (P=0.000). Among them, the cognitive and functional benefits of Shen-reinforcing therapy for very early AD (350 cases) for 1 year were better than the placebo (P<0.001), and the dementia conversion rate was reduced by 8.85% (P=0.002). The behavioral symptomatic relief of patients with vascular dementia received fire-purging therapy (540 cases) was superior to those received CT (P=0.016). These data suggested that the STEP regimen has synergistic effects on CTs at least in terms of cognitive benefit, and the earlier the use, the greater the benefit will have. Therefore, the STEP regimen should be considered as one of the clinical options, particularly for the dearth of effective pharmaceutical or immunological interventions that are currently available for AD. 相似文献
3.
4.
5.
J Phua E S C Koay D Zhang L K Tai X L Boo K C Lim T K Lim 《The European respiratory journal》2006,28(4):695-702
Levels of the soluble form of the triggering receptor expressed on myeloid cells (sTREM)-1 are elevated in severe sepsis. However, it is not known whether sTREM-1 measurements can distinguish milder bacterial infections from noninfectious inflammation. The present authors studied whether serum sTREM-1 levels differ in community-acquired pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD), asthma and controls, and whether sTREM-1 may be used as a surrogate marker for the need for antibiotics. Serum sTREM-1 levels in 150 patients with pneumonia, COPD and asthma exacerbations and 62 healthy controls were measured. Serum sTREM-1 levels were significantly elevated in pneumonia (median 295.2 ng x mL(-1)), COPD (280.3 ng x mL(-1)) and asthma exacerbations (184.0 ng x mL(-1)) compared with controls (83.1 ng x mL(-1)). Levels were higher in pneumonia and Anthonisen type 1 COPD exacerbations than in type 2 and 3 COPD and asthma exacerbations. The area under the receiver operating characteristics curve for sTREM-1 as a surrogate marker for the need for antibiotics was 0.77. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 were elevated predominantly in pneumonia and Anthonisen type 1 COPD exacerbations versus type 2 and 3 chronic obstructive pulmonary disease exacerbations, asthma and controls. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 has moderate but insufficient accuracy as a surrogate marker for the need for antibiotics in lower respiratory tract infections. 相似文献
6.
肛直肠抑制反射时门静脉血中P物质变化 总被引:1,自引:0,他引:1
目的探讨肛直肠抑制反射(RAIR)时门静脉血中P物质(SP)的变化规律及外源性内脏神经对其变化的影响。方法将实验大白鼠分为7组,其中6组先按去与不去直肠肛管外源性内脏神经支配而分为不去神经和去神经两大组,每组中又按Foley导管上气囊置入直肠腔中的位置分为2、4、6cm组;同时再设1个对照组,将Foley导管置入直肠腔中,但不注水扩张球囊。检测并比较在直肠腔内刺激后,各组门静脉血中的SP值及变化情况。结果去神经组中2、4cm组与不去神经组之间及对照组之间,门静脉血中SP值变化比较,P〉0.05,差异无统计学意义。不去神经组中的6cm组与对照组及去神经组中2cm和4cm组之间SP值比较,P〈0.01,差异有统计学意义;去神经组和不去神经组中的6cm组之间SP值比较,P〈0.01,差异有统计学意义。结论直肠腔内上部的刺激不引出RAIR可能与该部位的刺激使内括约肌兴奋性递质(SP)的释放有关;外源性内脏神经对RAIR中门静脉血的SP变化有调控作用。 相似文献
7.
周围性面瘫,多是由面神经炎引起面神经缺血、水肿导致的面肌瘫痪[1].笔者近年在沙特阿拉伯工作期间,有感于面部按摩疗法在周围性面瘫康复中的广泛应用,以面部游走火罐配合针灸疗法治疗本病35例,均取得了较好的疗效.现总结如下. 相似文献
8.
9.
灰关联分析应用于因素分析时关联度指标的改进 总被引:8,自引:1,他引:7
本文指出在应用灰关联分析进行因素分析时传统的关联度计算方法的不足,并提出采用新的关联度指标来表示因素之间的关联关系,同时给出了实例介绍计算方法。 相似文献
10.
A. HAZIOT I. KATZ G. W. RONG X. Y. LIN J. SILVER & S. M. GOYERT 《Scandinavian journal of immunology》1997,46(3):242-245
Membrane-bound CD14 acts as a receptor for lipopolysaccharide (LPS) on monocytes/macrophages and neutrophils. Studies have suggested that the activation of monocytes/macrophages by the binding of LPS to membrane-bound CD14 may require the association of a signal-transducing molecule with membrane-bound CD14. The observation that non-CD14 expressing cells, such as endothelial cells, can nevertheless be activated by a complex of LPS and a soluble form of CD14 (sCD14) suggests that the receptor for this complex may be identical to the signal transducing molecule associated with membrane-bound CD14. The studies described show that two CD14-specific MoAb are able to block the LPS-induced activation of endothelial cells but do not affect the response of monocytes to LPS. This suggests that the interaction of the sCD14:LPS complex with endothelial cells is distinct from the interaction of membrane-bound CD14 with its putative signal-transducing molecule. 相似文献